FDA Approves Bavarian Nordic’s Chikungunya Vaccine or Those 12 and Older
Bavarian Nordic is a vaccine company focused on developing and manufacturing vaccines for infectious diseases. Bavarian Nordic received approval from the US Food and Drug Administration (FDA) for its Vimkunya chikungunya vaccine for individuals aged 12 and older. The vaccine, the first virus-like particle (VLP) single-dose vaccine for chikungunya, was approved based on phase 3 […]
Communicable disease threats report, 8 – 14 February 2025, week 7
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8-14 February and includes updates on STI cases, chikungunya, Ebola, measles, avian influenza A (H9N2, H5N1), swine influenza A(H1N2), influenza (H10N3) and an overview of respiratory virus epidemiology in the EU/EEA. Source link
Navigating Clinical Trust Amid Political Shifts
Recent changes in US health policy have raised serious concerns within the global health community. In a recent Lancet correspondence, Su H Wang, MD, FACP, MPH, and fellow clinicians and public health experts highlighted the alarming impact of the US administration’s decisions to withdraw from the World Health Organization (WHO), halt vital CDC communications, and […]
US Health Policy Changes Threaten Global Public Health Cooperation
Recent changes in US health policy have raised serious concerns within the global health community. In a recent Lancet correspondence, Su H Wang, MD, FACP, MPH, and fellow clinicians and colleagues from the public health community came together and highlighted the alarming impact of the US administration’s decisions to withdraw from the World Health Organization […]
